Neuroone Medical Technologies CorpNASDAQ:NMTC
- LAST PRICE1.1400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.1300/ 1
- Ask / Lots1.1700/ 200
- Open / Previous Close1.1400 / 1.1400
- Day Range
- 52 Week Range
- Volume52,236
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMTC |
|---|---|---|
| 09:32 ET | 200 | 1.14 |
| 09:54 ET | 1000 | 1.1302 |
| 09:56 ET | 5200 | 1.1329 |
| 10:03 ET | 1810 | 1.1257 |
| 10:14 ET | 100 | 1.12 |
| 10:15 ET | 723 | 1.13 |
| 10:48 ET | 1958 | 1.13 |
| 10:50 ET | 1500 | 1.135 |
| 10:57 ET | 100 | 1.13 |
| 11:06 ET | 979 | 1.12 |
| 11:09 ET | 1055 | 1.1264 |
| 11:13 ET | 400 | 1.13 |
| 11:18 ET | 201 | 1.13 |
| 11:22 ET | 200 | 1.12 |
| 11:26 ET | 100 | 1.125 |
| 11:29 ET | 2000 | 1.125 |
| 11:45 ET | 100 | 1.13 |
| 12:59 ET | 12000 | 1.14 |
| 01:10 ET | 100 | 1.13 |
| 01:37 ET | 333 | 1.13 |
| 02:26 ET | 1000 | 1.1246 |
| 02:42 ET | 998 | 1.13 |
| 02:47 ET | 200 | 1.13 |
| 02:51 ET | 100 | 1.12 |
| 02:56 ET | 191 | 1.1201 |
| 03:25 ET | 100 | 1.12 |
| 03:27 ET | 100 | 1.12 |
| 03:36 ET | 100 | 1.12 |
| 03:39 ET | 500 | 1.12 |
| 03:43 ET | 550 | 1.134 |
| 03:52 ET | 10000 | 1.14 |
| 03:56 ET | 3027 | 1.14 |
| 03:57 ET | 2004 | 1.135 |
| 03:59 ET | 758 | 1.14 |
Apr 10, 2024
NeuroOne(R) CEO Dave Rosa Featured on Bloomberg Technology, from 9:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
9:00AM ET on Wednesday Apr 10, 2024 by Dow JonesNeuroOne(R) CEO Dave Rosa Featured on Bloomberg Technology, from 9:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
9:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 9, 2024
NeuroOne(R) Announces First Implant of OneRF(TM) Ablation Electrodes, from 9:05AM ET on Tuesday Apr 09, 2024 by Dow Jones
9:05AM ET on Tuesday Apr 09, 2024 by Dow Jones
Apr 4, 2024
NeuroOne(R) CEO Dave Rosa Featured on Fox Business Network's Varney & Co., from 9:00AM ET on Thursday Apr 04, 2024 by Dow Jones
9:00AM ET on Thursday Apr 04, 2024 by Dow JonesNeuroOne(R) CEO Dave Rosa Featured on Fox Business Network's Varney & Co., from 9:00AM ET on Thursday Apr 04, 2024 by Dow Jones
9:00AM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neuroone Medical Technologies Corp | 29.6M | -1.6x | --- |
Positron Corp | 31.2M | -12.8x | --- |
Renalytix PLC | 45.3M | -0.8x | --- |
PAVmed Inc | 17.2M | -0.2x | --- |
LiveCare Inc | 28.0M | -4.5x | --- |
Akili Inc | 18.0M | -0.3x | --- |
Company Information
NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.
Contact Information
- Headquarters
- 7599 Anagram DrEDEN PRAIRIE, MN, United States 55344-7399
- Phone
- 952-426-1383
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Buckman
- President, Chief Executive Officer, Director
- David Rosa
- Co-Founder, Business Development Director - Medical Sales Liaison
- Mark Christianson
- Chief Financial Officer
- Ronald Mcclurg
- Chief Operating Officer
- Christopher Volker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $29.6M |
|---|---|
Revenue (TTM) | $2.9M |
Shares Outstanding | 25.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.05 |
EPS | $-0.69 |
Book Value | $0.26 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 10.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -474.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
